Setmelanotide Acetate Patent Expiration
Setmelanotide Acetate was first introduced by Rhythm Pharmaceuticals Inc
Setmelanotide Acetate Patents
Given below is the list of patents protecting Setmelanotide Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Imcivree | US11129869 | Pharmaceutical compositions | Jul 04, 2034 | Rhythm |
| Imcivree | US8039435 | Melanocortin receptor ligands | Oct 13, 2027 | Rhythm |
| Imcivree | US9458195 | Melanocortin receptor ligands | Oct 13, 2027 | Rhythm |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳